Literature DB >> 20160470

Impairment of cardiovascular autonomic pattern in obese adolescents with Type 2 diabetes mellitus.

F Cerutti1, F Rabbia, I Rabbone, A Bobbio, M G Ignaccolo, G Greco, M C Bertello, P Mulatero, F Veglio, G Pacini.   

Abstract

UNLABELLED: The aim of this study was to assess the behaviour of insulin sensitivity and insulin resistance (IR) indexes in a group of obese adolescents with Type 2 diabetes mellitus (T2DM) in comparison to obese adolescents without diabetes and normal controls, moreover to compare these parameters with the cardiac autonomic pattern. Seven T2DM obese (12.7 ± 0.5 yr), 18 obese without T2DM, and 10 nonobese control adolescents age matched were studied. In all subjects we performed oral glucose tolerance test (OGTT) with insulin and glucose determination, 24-h electrocardiogram Holter, blood pressure monitoring, ecohocardiogram.
RESULTS: serum lipids were significantly higher in obese and T2DM. Insulin sensitivity was significantly reduced in T2DM and obese vs controls; T2DM showed a more pronounced oral glucose insulin sensitivity (OGIS) reduction vs obese. Both obese and T2DM presented an higher IR. T2DM showed an impaired β-cell function, with insulin areas under the curve and disposition index significantly reduced in comparison to controls and obese who showed similar values. A progressive reduction of vagal indexes and an increase of sympathetic indexes were found in obese adolescents and were more pronounced in T2DM. These parameters were correlated with OGIS and β-cell function parameters in both obese and T2DM adolescents. T2DM showed a significant relative wall thickness increase suggesting a trend toward concentric remodeling. In conclusion, T2DM adolescents are characterized by a more marked IR reduced β-cell function in comparison to non-diabetic obese. These modifications may lead to an early impairment of the autonomic pattern.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160470     DOI: 10.1007/BF03346644

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance.

Authors:  Catherine W Yeckel; Sara E Taksali; James Dziura; Ram Weiss; Tania S Burgert; Robert S Sherwin; William V Tamborlane; Sonia Caprio
Journal:  J Clin Endocrinol Metab       Date:  2004-11-02       Impact factor: 5.958

3.  Early-onset insulin-resistant diabetes in obese Caucasians has features of typical type 2 diabetes, but 3 decades earlier.

Authors:  Siobhan McQuaid; Donal J O'Gorman; Obada Yousif; Toh Peng Yeow; Yusof Rahman; Declan Gasparro; Giovanni Pacini; John J Nolan
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

Review 4.  Mechanisms of sympathetic activation in obesity-related hypertension.

Authors:  Murray Esler; Nora Straznicky; Nina Eikelis; Kazuko Masuo; Gavin Lambert; Elisabeth Lambert
Journal:  Hypertension       Date:  2006-09-25       Impact factor: 10.190

5.  Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.

Authors:  Muhammad A Abdul-Ghani; Christopher P Jenkinson; Dawn K Richardson; Devjit Tripathy; Ralph A DeFronzo
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

6.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

7.  A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.

Authors:  A Mari; G Pacini; E Murphy; B Ludvik; J J Nolan
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

8.  Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study.

Authors:  J P Singh; M G Larson; H Tsuji; J C Evans; C J O'Donnell; D Levy
Journal:  Hypertension       Date:  1998-08       Impact factor: 10.190

9.  Insulin secretion and hepatic insulin clearance as determinants of hyperinsulinaemia in normotolerant grossly obese adolescents.

Authors:  F Cerutti; C Sacchetti; A Bessone; I Rabbone; P Cavallo-Perin; G Pacini
Journal:  Acta Paediatr       Date:  1998-10       Impact factor: 2.299

10.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

Authors:  A Gastaldelli; E Ferrannini; Y Miyazaki; M Matsuda; R A DeFronzo
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

View more
  4 in total

Review 1.  Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes.

Authors:  Fida Bacha; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

2.  Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial.

Authors:  Lorraine Levitt Katz; Samuel S Gidding; Fida Bacha; Kathryn Hirst; Siripoom McKay; Laura Pyle; Joao A C Lima
Journal:  Pediatr Diabetes       Date:  2014-01-22       Impact factor: 4.866

3.  Abnormalities in autonomic function in obese boys at-risk for insulin resistance and obstructive sleep apnea.

Authors:  Flavia M S Oliveira; Winston H Tran; Daniel J Lesser; Rajeev Bhatia; Thomas G Keens; Steven D Mittelman; Sally L Davidson Ward; Michael C K Khoo
Journal:  Pediatr Res       Date:  2018-11-12       Impact factor: 3.756

4.  Cardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 Diabetes.

Authors:  Petter Bjornstad; Uyen Truong; Jennifer L Dorosz; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Laura Pyle; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau
Journal:  J Am Heart Assoc       Date:  2016-03-18       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.